openPR Logo
Press release

Medikonia announces distributor agreement with Pathway Genomics To bring its DNA tests and AI Analysis to Hong Kong

08-15-2017 11:15 AM CET | Health & Medicine

Press release from: Medikonia

Hong Kong, 15/08/2017.
Medikonia, a solution –based genomics service provider in Hong Kong, announced today it has signed distributorship agreement with Pathway Genomics to bring its wide range of clinical genetic testing with advanced Artificial Intelligence analysis available to Hong Kong.

“Our goal is simple: bring reliable, accurate and actionable precision healthcare information to users and help them discover his/her own path to healthier life.” said Joe Lai, Medikonia’s Chief Executive Officer. “Pathway genomics is one of the best global precision medical diagnostic companies, offering a wide rage advanced clinical genetic testing. It is our honor to bring its service to Hong Kong. ”

Jim Plante, CEO and Founder of Pathway, said “Asia is an enormous emerging market for genetic testing. We are very pleased to align ourselves with a passionate partner like Medikonia to extend our global reach to Asia “

ABOUT MEDIKONIA:
Established in 2015, Medikonia, based in Hong Kong, is a fast growing solution –based genomics service provider. We provide solutions to professors and researchers in universities and laboratories, helping genomic research easier; meanwhile, we empower people with actionable genetics information, discovering his/her own path to healthier life. For more about medikonia, visit www.medikonia.com

ABOUT PATHWAY GENOMICS:
Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with actionable and accurate precision healthcare information to improve health and wellness. The company’s program with IBM Watson is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history. For more about Pathway Genomics, visit www.pathway.com

CONTACT:

MEDIKONIA:
Unit 2302, 23/F, New World Tower 1, Central, Hong Kong
Kiwi Lai, Marketing Manager
Tel: +852 2866 8069
Emai: cs@medikonia.com

PATHWAY GENOMICS:
4755 Nexus Center Drive,San Diego CA, 92121,USA
Blythe Lawton, Senior Director, Marketing
Tel:+1 858.568.7002
Email:pr@pathway.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medikonia announces distributor agreement with Pathway Genomics To bring its DNA tests and AI Analysis to Hong Kong here

News-ID: 668946 • Views:

More Releases for Hong

Hong Kong Maritime Week 2024 Kicks Off, Highlighting Hong Kong's Role as a Globa …
Hong Kong, 18 November 2024 - The highly anticipated Hong Kong Maritime Week 2024 (HKMW 2024) officially launched today, bringing together distinguished leaders from the maritime and port industries both locally and internationally. This annual event, a cornerstone of Hong Kong's maritime calendar, aims to bolster the city's position as a premier international maritime centre. Under the theme "Navigating to a Greener Future", HKMW 2024 will showcase "Propel Hong Kong" to
The Hong Kong Monetary Authority Fines DBS Bank (Hong Kong) Over AML Violations!
On July 5, 2024, the Hong Kong Monetary Authority (HKMA) announced that it had imposed a pecuniary penalty of HK$10,000,000 ($1.3 million) on DBS Bank (Hong Kong) for contraventions of the Anti-Money Laundering and Counter-Terrorist Financing Ordinance (AMLO). The fine was issued following an investigation that revealed several control deficiencies at DBS Bank: Failure to Monitor Business Relationships: DBS failed to continuously monitor business relationships and conduct enhanced due diligence in
Hong Kong Wealth Management Market Report- Business Review, Technology, Top Comp …
Hong Kong Wealth Management Market research report helps in gathering and analysing useful insights such as global market size, forecast and Compound Annual Growth Rate (CAGR) of a particular industry. It also helps in determining the market status, future prospects, growth opportunity, main challenges about the market for any industry. Hong Kong Wealth Management Market research report also provides complete analysis of the industry, current market trend, overview of the
Hong Kong National Film Festival
On May 27, 2017 in the Kowloon Walled City (Hong Kong) the annual Hong Kong National Film Festival was held. This event featured 13 films in various genres: drama, documentary, animated film, etc. None of the participants of the Hong Kong National Film Festival were deprived of attention! The winners were awarded certificates, and all those who were a little less lucky this year were awarded memorable prizes and awards. The
Country Snapshot: Hong Kong; Overview of the consumer payments market in Hong Ko …
Summary Hong Kong represents a mature payment card market in Asia, with 25 million payment cards in issue and a population of over 7 million. Despite a high card per customer ratio, Hong Kong is expected to see mild growth in both card numbers and the value of transactions in the coming years. Key Findings – Pay-later cards are the fastest growing payment card segment in Hong Kong, mostly driven by the popularity
Equities First Holdings Hong Kong Limited Receives Reconfirmation of Hong Kong M …
The Hong Kong Money Lenders License was granted by the Hong Kong Eastern Magistrates Courts. Hong Kong, China -- Equities First Holdings Hong Kong Limited, the Asian subsidiary of Equities First Holdings, LLC (EFH, http://www.equitiesfirst.com) a global securities-based lender and a leader in alternative shareholder financing solutions, has received reconfirmation of its Hong Kong Money Lenders License from the Hong Kong Eastern Magistrates Courts. This license enables EFH to act as a